Sentence examples for notable endpoint from inspiring English sources

Other notable endpoint players include disruptive Cylance, which recently earned its horn and unicorn status raising $100 million, as well as Tanium, CarbonBlack, and Invincea.

Another notable endpoint was the 10MCP Trans VASCi which demonstrated significant effect sizes in both Panels at Day 15 and 8 (largest effect size was within Panel A, Day 15 = 1.38).

However, only four of these studies reported the effects of such tools on the notable clinical endpoints of hospital readmission, post-discharge mortality, and adverse events [ 14], and in doing so, none had sufficient statistical power to assess these endpoints.

Both 15 mg and 7.5 mg prednisone represent relatively low corticosteroid doses and it would be notable if an endpoint could differentiate their effect.

In recent years, there has been extensive and very public scientific debate about the ED potential of several notable agents, including what endpoints might be affected and how contradictory evidence on these matters should be evaluated - a process that has included many reviews and evaluations of the evidence by expert panels convened by scientists and regulatory authorities.

Most notable was the use of different endpoints; some studies used histologic endpoints that included CIN2, while other studies used cytologic HSIL to define disease.

There were other notable findings concerning risk factors for specific endpoints as well.

The combination of rituximab fludarabine and cyclophosphamide (FCR) was shown to be superior to FC for all clinical endpoints including overall survival (OS), with the notable exception of the 17p− and the "normal FISH" subgoups 13.

With respect to hematologic or serum chemistry laboratory results that differed from baseline, there were few abnormal results during the entire study; consequently, there were no notable differences among groups in the proportion of subjects who reached this endpoint.

However, a notable drawback of a binary representation of interaction data is that missing endpoints for non-interacting drug target pairs are not differentiated from inactive cases, and that predicted levels of activity depend on pre-defined binarization thresholds.

Despite the overall improved study quality, again, various methodological weak points were notable in the analysed studies, including: Lack of a priori definition of the primary endpoint (to be tested in a confirmatory manner) and lack of an unambiguous delimitation for the secondary endpoints (to be analysed descriptively/exploratively).